Sartorius's virus removal filter (Virosart) and membrane chromatography modules (Sartobind) form an integral part of the company's commitment to biopharmaceutical manufacturing excellence
Total reliability in purification technologies allied to speed and efficiency is the motivation behind the development and release of Sartorius's virus removal filter (Virosart) and membrane chromatography modules (Sartobind).
The two products form an integral part of the Sartorius commitment to biopharmaceutical manufacturing excellence.
The Sartobind range leads the way in membrane adsorber technology, whether it is chromatography based contaminant removal or product purification.
Offering a microporous structure with a pore size of 3um and a unique membrane for purification of large proteins and virus particles, it is capable of ten times more dynamic capacity for DNA than conventional beads.
In the field of viral clearance, Virosart CPV has been targeted and developed for the removal of relevant and adventitious viruses from biopharmaceutical feed streams.
With a retention of more than 4log of parvo viruses and 6log of retroviruses Virosart CPV offers the highest levels in viral safety together with a maximised flow rate and capacity for the ultimate in streamlined operation.
Virosart is also fully scalable from lab scale (cm2) up to production scale (m2) - which enables users to accurately make adjustments for full process scale up.